Marchio Vincenzo, Derchi Giacomo, Cinquini Chiara, Miceli Marco, Gabriele Mario, Alfonsi Fortunato, Barone Antonio
Unit of Stomatology and Oral Surgery, Department of Surgical, Medical, Molecular and Critical Needs Pathologies, University Hospital of Pisa, University of Pisa, Pisa Italy -
Unit of Stomatology and Oral Surgery, Department of Surgical, Medical, Molecular and Critical Needs Pathologies, University Hospital of Pisa, University of Pisa, Pisa Italy.
Minerva Stomatol. 2020 Oct;69(5):295-301. doi: 10.23736/S0026-4970.20.04359-9. Epub 2020 May 14.
Dental implants placed in medically compromised patients have predictable outcomes and a high rate of survival, compared to those placed in healthy patients. The aims of this study were to observe and compare implant survival/success rates and soft tissue response to tissue-level implants placed in healthy and medically compromised patients with a 1-year follow-up.
Seventy-two patients, 36 healthy patients (20 females and 16 males) and 36 medically compromised patients (18 females and 18 males) affected by cardiovascular diseases (arrythmia, hypertension, atrial fibrillation, bypass and pacemaker surgery), depression, endocrine metabolic diseases (hypercholesterolemia, type II diabetes, Hashimoto's thyroiditis), gastrointestinal diseases (gastritis, hiatal hernia, gastric ulcers), asthma, osteoporosis or glaucoma received one tissue-level implant. Measurements for primary and secondary outcomes were collected immediately after implant placement and at 1 year from implant insertion.
Three were failed and two were survived out of a total of 72 implants. Among healthy patients, two implants failed while one was classified as survived; among Medically compromised patients one implant failed and another one was classified as survived. No statistically significant difference was found between the two groups in terms of success rate or survival rate. No statistically significant differences between the two groups' marginal bone level was observed. In healthy patients a mean loss of keratinized tissue (-0.1±0.6 mm) was reported, while in medically compromised patients a mean gain was reported (+0.5±0.8 mm).
In terms of success, failure and survival rates, tissue level implants placed in healthy and in medically compromised individuals showed no short-term (1 year) differences.
与植入健康患者体内的牙种植体相比，植入有医学问题患者体内的牙种植体具有可预测的结果和较高的存活率。本研究的目的是观察和比较在健康和有医学问题的患者中植入组织水平种植体1年随访后的种植体存活率/成功率以及软组织反应。
72例患者，36例健康患者（20例女性和16例男性）和36例有医学问题的患者（18例女性和18例男性），这些有医学问题的患者患有心血管疾病（心律失常、高血压、心房颤动、搭桥手术和起搏器手术）、抑郁症、内分泌代谢疾病（高胆固醇血症、II型糖尿病、桥本甲状腺炎）、胃肠道疾病（胃炎、食管裂孔疝、胃溃疡）、哮喘、骨质疏松症或青光眼，均接受了一枚组织水平种植体。在种植体植入后立即以及植入后1年收集主要和次要结果的测量数据。
72枚种植体中，3枚失败，2枚存活。在健康患者中，2枚种植体失败，1枚被归类为存活；在有医学问题的患者中，1枚种植体失败，另1枚被归类为存活。两组在成功率或存活率方面未发现统计学上的显著差异。两组的边缘骨水平未观察到统计学上的显著差异。健康患者报告角化组织平均丧失（-0.1±0.6毫米），而有医学问题的患者报告平均增加（+0.5±0.8毫米）。
在成功率、失败率和存活率方面，植入健康个体和有医学问题个体体内的组织水平种植体在短期（1年）内没有差异。
